Broadly, these results provide evidence that induction of NF-κB signalling, mediated by α4β1/VCAM-1, αvβ3/periostin and αvβ5/periostin interactions in B-ALL cells, may contribute to reducing the cytotoxic effects of commonly used B-ALL chemotherapeutics. Here, VCAM1 is linked to acute lymphoblastic leukemia.